News Congress urges feds to examine drug companies aiming to turn opioid settlements to tax breaks

thegreenhand

Bluelight Crew
Joined
Aug 16, 2019
Messages
4,682
Location
a wooded hollow

Congress urges feds to examine drug companies aiming to turn opioid settlements to tax breaks​

Douglas MacMillan
Washington Post
14 Mar 2022

Congress is calling on federal officials to review the plans of four large drug companies to deduct the cost of a landmark opioid settlement from their taxes, after its year-long investigation into corporate disclosures first revealed in an analysis by The Washington Post.

On Thursday, the House Committee on Oversight and Reform sent a letter asking the Justice and Treasury departments to examine planned deductions from Johnson & Johnson, McKesson, Cardinal Health and AmerisourceBergen. The four firms are seeking tax breaks that would help offset the cost of a $26 billion legal settlement finalized last month, to bring funds to communities hurt by the opioid epidemic.

Read the full article here.
 
Top